These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4735101)

  • 1. Morphine withdrawal syndrome responses to cholinergic antagonists and to a partial cholinergic agonist.
    Pinsky C; Frederickson RC; Vazquez AJ
    Nature; 1973 Mar; 242(5392):59-60. PubMed ID: 4735101
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cholinergic and anticholinergic drugs and a partial cholinergic agonist on the development and expression of physical dependence on morphine in rat.
    Frederickson RC; Pinsky C
    J Pharmacol Exp Ther; 1975 Apr; 193(1):44-55. PubMed ID: 1169318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of precipitated morphine and methadone abstinence in mice by acetylcholine antagonists.
    Jhamandas K; Dickinson G
    Nat New Biol; 1973 Oct; 245(146):219-21. PubMed ID: 4518142
    [No Abstract]   [Full Text] [Related]  

  • 4. Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?
    Taraschenko OD; Panchal V; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2005 Apr; 513(3):207-18. PubMed ID: 15862802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholinergic drugs on acute and chronic morphine dependence.
    Padmanabha Pillai N; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):146-54. PubMed ID: 7202346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
    Buccafusco JJ; Zhang LC; Shuster LC; Jonnala RR; Gattu M
    Brain Res; 2000 Jan; 852(1):76-83. PubMed ID: 10661498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of hippocampal phosphatidylethanolamine-binding protein in morphine dependence and withdrawal.
    Wei QH; Wu N; Bian JM; Chen Y; Su RB; Li J
    Addict Biol; 2013 Mar; 18(2):230-40. PubMed ID: 21967037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine withdrawal response and central cholinergic activity.
    Frederickson RC
    Nature; 1975 Sep; 257(5522):131-2. PubMed ID: 1172193
    [No Abstract]   [Full Text] [Related]  

  • 10. Modification of the morphine withdrawal syndrome in rats.
    Fertziger AP; Lynch JJ; Stein E
    Brain Res; 1974 Sep; 78(2):331-4. PubMed ID: 4859416
    [No Abstract]   [Full Text] [Related]  

  • 11. Agonists and antagonists of adenosine receptors and morphine withdrawal syndrome in rats.
    Michalska E; Malec D
    Pol J Pharmacol; 1993; 45(1):1-9. PubMed ID: 8401754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice.
    Zhang G; Wu X; Zhang YM; Liu H; Jiang Q; Pang G; Tao X; Dong L; Stackman RW
    Neuropharmacology; 2016 Feb; 101():246-54. PubMed ID: 26432939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine withdrawal in the rat: assessment by quantitation of diarrhea and modification by ethanol.
    Ho AK; Chen RC; Kreek MJ
    Pharmacology; 1979; 18(1):9-17. PubMed ID: 570271
    [No Abstract]   [Full Text] [Related]  

  • 15. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: Pharmacological modification by arecoline.
    Buccafusco JJ; Bain JN
    Neuroscience; 2007 Nov; 149(3):487-98. PubMed ID: 17916413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory influence of mecamylamine on ethanol withdrawal-induced symptoms in C57BL/6J mice.
    Bhutada PS; Mundhada YR; Bansod KU; Umathe SN; Kahale VP; Dixit PV; Mundhada DR
    Behav Pharmacol; 2010 Mar; 21(2):90-5. PubMed ID: 20168214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cholinergic agonists and antagonists on morphine withdrawal induced aversion to saccharin drinking in rats.
    Pillai NP; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Indian J Exp Biol; 1984 Feb; 22(2):113-4. PubMed ID: 6541193
    [No Abstract]   [Full Text] [Related]  

  • 18. The short- and long-termed effects of beta-endorphin on the opiate abstinence syndrome in rats.
    Haracz JL; Tseng LF
    Commun Psychopharmacol; 1980; 4(3):219-24. PubMed ID: 6262008
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of bradykinin, vasopressin and ACTH (4-10) on the morphine withdrawal syndrome in morphine-dependent rats of 2 inbred strains].
    Sudakov SK; Liupina IuV; Medvedeva OF; Tiurina IV
    Eksp Klin Farmakol; 1997; 60(4):14-6. PubMed ID: 9376748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.
    Hildebrand BE; Panagis G; Svensson TH; Nomikos GG
    Neuropsychopharmacology; 1999 Oct; 21(4):560-74. PubMed ID: 10481840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.